Quantum Use Case #8: Modelling antibiotic resistance

Short answer: This use case involves applying quantum machine learning and quantum-enhanced algorithms to predict antimicrobial resistance patterns and identify new chemical compounds with low resistance. It is currently a research-stage opportunity, with early simulations and limited experimental evaluations showing potential for parity or specific superiority over classical methods, though consistent outperformance has not yet been demonstrated.

The Challenge of Antimicrobial Resistance

Antimicrobial resistance (AMR) is recognized as a major threat to global public health. The World Health Organization has declared AMR one of the top ten threats to global public health. The issue carries significant economic, environmental, and societal costs. Estimates suggest that if AMR continues unchecked, additional millions could be forced into poverty by 2030. Despite these costs, the development of new antimicrobials has not kept pace with the emergence of resistant strains. Groups such as those with limited resources are hit the hardest by AMR. Current AI models struggle to predict resistance patterns quickly and accurately, creating a need for improved computational approaches.

Quantum Approaches to Prediction

Researchers have proposed using quantum computing to improve current AI models for predicting resistance patterns. One approach involves developing a quantum computing solution to identify new chemical compounds with low resistance on more targeted bacteria. This aims to address the gap between the emergence of resistance and the development of new treatments.

A specific study focused on Salmonella, a common foodborne pathogen that poses risks to public health safety due to the emergence of antimicrobial-resistant strains. Researchers proposed a predictive platform for Salmonella antimicrobial resistance based on a large language model (LLM) and quantum computing. This platform addresses the lack of systematic tools for Salmonella resistance prediction, data presentation, and data sharing. The proposed method includes a two-step feature-selection process based on the chi-square test and conditional logic, integrating quantum computing elements into the predictive framework.

Empirical Evaluation in Clinical Data

A recent study presented the first large-scale empirical evaluation of quantum machine learning for predicting antibiotic resistance in clinical urine cultures. The researchers developed a Quantum Projective Learning (QPL) approach. They executed 60 qubit experiments on IBM Eagle and Heron quantum processing units. This represents a move from theoretical simulation to experimental validation on existing hardware.

The results indicated that QPL did not consistently outperform classical baselines. This outcome potentially reflects current quantum hardware limitations. However, the approach did achieve parity or superiority in specific scenarios. Notably, the quantum method showed advantages for the antibiotic nitrofurantoin and in selected data splits. These findings reveal that quantum approaches may offer benefits in narrow contexts, even if they do not yet provide a universal solution.

Current Limitations and Hardware Constraints

The research suggests that quantum advantage in this domain is not yet robust. The failure to consistently outperform classical baselines highlights the constraints of current quantum hardware. While the QPL approach achieved parity or superiority in specific scenarios, such as for nitrofurantoin, these successes are not generalizable across all antibiotics or data splits.

The integration of large language models with quantum computing, as proposed for Salmonella prediction, remains in the proposal stage. The combination of LLMs and quantum computing aims to overcome the lack of systematic platforms for resistance prediction. However, the practical implementation of such hybrid systems is still under development. The reliance on specific hardware, such as the IBM Eagle and Heron units, underscores the dependency on current technological capabilities.

Future Directions

The research indicates that quantum machine learning may play a role in predicting antibiotic resistance, particularly in specific scenarios where classical methods struggle. The ability to identify new chemical compounds with low resistance is a key goal. However, the current state of the art suggests that quantum approaches are not yet ready for broad operational adoption.

Researchers continue to explore how quantum computing can improve the speed and accuracy of resistance prediction. The focus remains on developing solutions that can keep pace with the emergence of resistant strains. While the economic and societal costs of AMR are high, the development of new antimicrobials has not kept pace with the problem. Quantum computing offers a potential avenue to address this gap, but it remains a research-stage technology with limited empirical validation.

FAQ

What is the primary goal of using quantum computing for antibiotic resistance?

The primary goal is to improve current AI models to predict patterns of resistance more quickly and accurately. It also aims to identify new chemical compounds with low resistance on more targeted bacteria. This addresses the issue that the development of new antimicrobials has not kept pace with the emergence of resistant strains.

Has quantum machine learning outperformed classical methods in all scenarios?

No. Empirical evaluations show that quantum machine learning did not consistently outperform classical baselines. However, it did achieve parity or superiority in specific scenarios, notably for the antibiotic nitrofurantoin and selected data splits. This suggests that quantum approaches may have niche applications rather than universal superiority.

What hardware was used in the empirical evaluation of Quantum Projective Learning?

The study executed 60 qubit experiments on IBM Eagle and Heron quantum processing units. This represents a large-scale empirical evaluation of quantum machine learning for predicting antibiotic resistance in clinical urine cultures. The use of specific hardware highlights the current technological constraints of the field.

How does the proposed Salmonella predictive platform work?

The platform is based on a large language model and quantum computing. It includes a two-step feature-selection process based on the chi-square test and conditional logic. This approach aims to overcome the lack of systematic platforms for Salmonella resistance prediction, data presentation, and data sharing. It is currently a proposed solution rather than a deployed system.

Is this technology ready for commercial or operational deployment?

No. Most use cases are research-stage. The research indicates that quantum approaches have not yet demonstrated consistent superiority over classical methods. While specific scenarios show parity or superiority, the technology is not currently operational for broad commercial or clinical use. It remains an area of active research with significant limitations.